Imagine a patient recovering from brain or spinal surgery, only to face life-threatening complications due to a tiny tear in the dura mater—the protective membrane surrounding the brain and spinal cord. Cerebrospinal fluid leaks, a persistent challenge in neurosurgery, can lead to severe neurological issues or even death. For decades, neurosurgeons have struggled to achieve a "watertight" seal using traditional sutures or grafts, especially in cases with large tissue defects or minimally invasive procedures. Existing surgical sealants, while helpful, often fail due to poor adhesion on wet tissues, brittleness, and inadequate toughness.

"As neurosurgeons, we routinely open the dura to access the brain or spinal cord. But achieving a secure closure post-surgery can be incredibly challenging. Our current options—sutures or grafts—are limited by tissue conditions, defect size, or surgical constraints. Available sealants lack the adhesion and toughness needed to reliably prevent leaks," said Dr. Kyle Wu, a neurosurgeon involved in the research.

A groundbreaking collaboration between Harvard's Wyss Institute for Biologically Inspired Engineering, the John A. Paulson School of Engineering and Applied Sciences (SEAS), and neurosurgeons from Brigham and Women’s Hospital, The Ohio State University Wexner Medical Center, and James Cancer Hospital has yielded a transformative solution: the Dural Tough Adhesive (DTA). This multifunctional biomaterial addresses the critical limitations of existing repair methods and could redefine standards in neurosurgical care.

The research drew inspiration from an unlikely source—the dusky slug ( Arion subfuscus ). A decade ago, a team led by Wyss Institute’s Professor David Mooney discovered that while most tissue-adhesive research focused on surface bonding, few addressed internal cohesion or performance in wet environments. The slug’s unique mucus secretion, which allows it to anchor firmly to surfaces despite predators’ tugging, became the biological muse for their design.

"We sought natural paradigms for tissue sealing and regeneration. The slug’s adhesive mechanism, perfected by evolution, pointed us toward a solution," explained Dr. Benjamin Freedman, co-first author and former Wyss researcher.

The team engineered a medical-grade hydrogel with two interwoven polymer networks: a permanently cross-linked polyacrylamide network for elasticity and a reversibly cross-linked alginate network to dissipate mechanical stress. A chitosan-based adhesive layer (derived from crustacean shells) completed the composite, enabling robust sealing via chemical interactions with fluid-coated tissues. This "Tough Adhesive" (TA) platform had already shown promise in wound healing, tendon repair, and fetal surgery for neural tube defects—making it ideal for dura repair.

In ex vivo tests, DTA demonstrated significantly stronger adhesion to porcine dura than commercial sealants, withstanding higher pressures before failure—a critical advantage given the elevated intracranial pressures seen in conditions like tumors, strokes, or hydrocephalus. In vivo studies in rats confirmed DTA’s structural stability for at least four weeks, with biocompatibility matching existing products.

Human cadaver trials further validated its potential. "As neurosurgery shifts toward minimally invasive techniques, an ideal sealant must outperform sutures while being deployable in confined spaces," noted Dr. Wu. The team successfully delivered DTA through a cadaver’s nasal passage to seal a cranial base leak, resisting pressures far exceeding pathological ranges.

"This research opens new frontiers for neurosurgeons, potentially simplifying procedures and reducing patient risks. It exemplifies how foundational advances in biomaterials—like our TA platform—can catalyze progress across regenerative medicine," said Professor David Mooney.

In a pivotal translational experiment, the team repaired porcine spinal dura tears (anatomically akin to humans) comparing DTA patches to the commercial sealant DuraSeal. When subjected to simulated surgical pressure tests, DTA repairs never leaked at low pressures, while DuraSeal failed in 40% of cases. DTA maintained integrity even under extreme, non-physiological pressures.

Wyss Institute Founding Director Dr. Donald Ingber highlighted the collaboration as "a paradigm of interdisciplinary innovation—where bioengineers and neurosurgeons jointly advance clinical solutions." The research, supported by the Wyss Institute and NIH (#K99/R00AG065495), included contributions from Dr. Wenya Linda Bi and colleagues at Harvard Medical School and Brigham and Women’s Hospital.

This breakthrough not only redefines dura repair but underscores biomimicry’s power to solve complex medical challenges. DTA heralds a safer era in neurosurgery, offering hope to countless patients at risk of cerebrospinal fluid leaks.